A Bayesian analysis of pharmacoeconomic data from a clinical trial on schizophrenia

Statistics in Medicine

Volumn 22, Issue 6, 2003, Pages 1025-1039

  Petit, Claude ^a   Maccario, Jean ^b  

^a LINCOLN Service Biométrie   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

Bayesian analysis; Clinical priors; Clinical trials; Cost effectiveness ratio; Pharmacoeconomic data; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; PLACEBO;

ABSENTEEISM; ANXIETY DISORDER; BAYES THEOREM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HEALTH CARE COST; HEALTH SERVICE; HOSPITALIZATION; HUMAN; LABORATORY TEST; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MOOD DISORDER; MULTICENTER STUDY; NEGATIVE SYNDROME; PHARMACOLOGICAL PARAMETERS; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SCHIZOPHRENIA; STATISTICAL ANALYSIS; SUICIDE ATTEMPT;

ANTIPSYCHOTIC AGENTS; BAYES THEOREM; BRIEF PSYCHIATRIC RATING SCALE; COST-BENEFIT ANALYSIS; ECONOMICS, PHARMACEUTICAL; HUMANS; MODELS, ECONOMIC; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA;

EID: 0037473226     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1458     Document Type: Review

References (23)

1. Berry DA. Bayesian methods in phase III trials. Drug Information Journal 1991; 25:345-368.
2. Berry DA. A case for Bayesianism in clinical trials. Statistics in Medicine 1993; 12:1377-1393.
3. Efron B. Why isn't everyone a Bayesian? American Statistician 1986; 40:1-11.
4. Freedman LS, Spiegelhalter DJ. Application of Bayesian statistics to decision making during a clinical trial. Statistics in Medicine 1992; 11:23-35.
5. Freedman LS, Spiegelhalter DJ, Parmar MKB. The what, why and how of Bayesian clinical trials monitoring. Statistics in Medicine 1994; 13:1371-1383.
6. Hughes MD. Reporting Bayesian analyses of clinical trials. Statistics in Medicine 1993; 12:1651-1663
7. Lewis RJ, Wears R. An introduction to the Bayesian analysis of clinical trials. Annals of Emergency Medicine 1993; 22(8):115-123.
8. Parmar MKB, Spiegelhalter DJ, Freedman LS. The CHART trial: Bayesian design and monitoring in practice. Statistics in Medicine 1994; 13(13/14):1297-1312.
9. Spiegelhalter DJ, Freedman LS. Bayesian Approaches to Clinical Trials -Bayesian Statistics 4. Oxford University Press: Oxford, 1988; 453-477.
10. Spiegelhalter DJ, Freedman LS, Parmar MKB. Applying Bayesian ideas in drug development and clinical trials. Statistics in Medicine 1993; 12:1501-1511.
11. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. An introduction to Bayesian methods in health technology assessment. British Medical Journal 1999; 319:508-512.
12. Whitehead J. The case for frequentism in clinical trials. Statistics in Medicine 1993; 12:1405-1413.
13. ICH. ICHE9 Statistical Principles for Clinical Trials. Step 4, Consensus guideline. 5 February 1998, The European Agency for the Evaluation of Medicinal Products.
14. Andreasen NC, Arndt S, Alliger R, Del Miller, Flaum M. Symptoms of schizophrenia: methods, meaning and mechanisms. Archives of General Psychiatry 1995; 52.
15. Lecrubier Y, Boyer P. Fiche descriptive et traduction française de la SANS. Psychiatrie et Psychobiologie 1987; 2:414-423.
16. Petit C. Doctorate thesis, Bibliothèque de l'université de médecine du Kremkin Bicêtre, France, 1999.
17. Freedman LS, Spiegelhalter DJ. The assessment of subjective opinion and its use in relation to stopping rules for clinical trials. Statistician 1983; 32:153-160.
18. Kullback S, Leibler RA. On information and sufficiency. Annals of Mathematical Statistics 1951; 22(1):79-86.
19. Kullback S. Information Theory and Statistics. Peter Smith: Gloucester, Mass., U.S.A., 1978.
20. Gury CH, Dechelette N, Gayral PH. Leponex: l'expérience du pharmacien hospitalier. L'Encéphale 1995; Sp III:61-65.
21. Bulletin Municipal officiel de la Ville de Paris du 29 décembre 1995: tarifs (journaliers) applicables dans les établissements de l'Assistance Publique de Paris à compter du ler janvier 1996.
22. Rouillon F, Dansette GY, Le Floch C. Etude de la prise en charge thérapeutique des schizophrènes et de son coût. L'Encéphale 1994; 20:303-309.
23. Groupe des spécialistes de santé publique de la faculté de médecine de Bordeaux. Le coût des tentatives de suicide et des suicides. Gestions Hospitalières